CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 147 filers reported holding CONMED CORP in Q3 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $483,000 | -96.5% | 5,040 | -94.5% | 0.00% | -96.3% |
Q1 2022 | $13,692,000 | +231.2% | 92,171 | +216.1% | 0.05% | +217.6% |
Q4 2021 | $4,134,000 | -62.3% | 29,162 | -65.2% | 0.02% | -64.6% |
Q3 2021 | $10,952,000 | +67.0% | 83,711 | +43.0% | 0.05% | +50.0% |
Q4 2020 | $6,558,000 | -90.2% | 58,556 | -93.1% | 0.03% | -90.6% |
Q3 2020 | $66,676,000 | -18.9% | 847,537 | -25.8% | 0.34% | -36.5% |
Q2 2020 | $82,260,000 | +201.1% | 1,142,653 | +139.5% | 0.54% | +141.9% |
Q1 2020 | $27,320,000 | +133.1% | 477,047 | +355.2% | 0.22% | +258.1% |
Q4 2019 | $11,719,000 | +74.7% | 104,797 | +50.2% | 0.06% | +51.2% |
Q3 2019 | $6,708,000 | -89.4% | 69,766 | -90.6% | 0.04% | -87.6% |
Q2 2019 | $63,328,000 | +1.7% | 740,076 | -1.1% | 0.33% | +17.0% |
Q1 2019 | $62,253,000 | +501.9% | 748,411 | +364.6% | 0.28% | +454.9% |
Q4 2018 | $10,343,000 | -23.9% | 161,100 | -43.4% | 0.05% | -44.6% |
Q2 2016 | $13,594,000 | +1036.6% | 284,800 | +950.9% | 0.09% | +1050.0% |
Q2 2014 | $1,196,000 | – | 27,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |